This paper also showed that earlier administration of anti-CTLA-4 after VSV was most effective at controlling tumor growth whilst, no therapy was achieved if anti-CTLA-4 was administered seven days after VSV therapy. The gene discussed is CTLA4; the disease is neoplasm.